Work

Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials

Year: 2023

Type: article

Source: American Heart Journal

DOI: 10.1016/j.ahj.2023.08.007

Authors: Jonathan D. Newman, Rebecca Anthopolos, Kelly V. Ruggles, Macintosh Cornwell, Harmony R. Reynolds, Sripal Bangalore, Kreton Mavromatis, Claes Held, Lars Wallentin, Iftikar J. Kullo, Bruce McManus, L. Kristin K． Newby, Yves Rosenberg, Judith S. Hochman, David J. Maron, Jeffrey S. Berger

Institutions: New York University, NYU Langone Health, Emory University, Uppsala University, Mayo Clinic, University of British Columbia, Duke University, National Institutes of Health, Stanford Medicine, Stanford University

Language: English

Topic: Cardiac Imaging and Diagnostics

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Health and Human Services, Abbott Laboratories, Amgen, Pfizer, Philips, AstraZeneca, CSL Behring, Regeneron Pharmaceuticals, Arbor Pharmaceuticals, Omron Healthcare, AstraZeneca HealthCare Foundation, National Institutes of Health, St. Jude Medical, Abbott Vascular, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences

Awards: G1859754121, G2182918659, G2273713241, G3093335914, G3242609308, G4765878343, G5582330655, G5936072485, G6881833145, G9000149767, G9000180944, G9000257432, G9000301115, G9000322374, G95160140

OpenAlex ID: W4386003502

FWCI: 2.544

Cites: 52

Cited by: 17

Related to: 10